Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1

Post time Half hour(s) ago

journal：Journal of Clinical Oncology

Authors：Birgitte V. Offersen; Jan Alsner; Kristine Hgsbjerg; Hanne M. Nielsen; Else Maae; Mette H. Nielsen; Ingvil Mjaaland; Maja V. Maraldo; Carine Kirkove; Tamas Lrincz; Sami Al-Rawi; Egil S. Blix; Andreas Schreiber; Mechthild Krause; Unn-Miriam Kasti; Louise W. Matthiessen; Camilla Kronborg; Trine Tramm; Maj-Britt Jensen; Jens Overgaard;

Published date：--

DOI：10.1200/jco-25-02705

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/JCO-25-02705

Article link：https://doi.org/10.1200/jco-25-02705

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

[Other] Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1 Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1